GenSight Biologics S.A.
GenSight Biologics S.A. (GSGTF) Stock Competitors & Peer Comparison
See (GSGTF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GSGTF | $0.24 | +0.00% | 478.2M | -8.16 | -$0.38 | N/A |
| NONOF | $54.40 | -22.22% | 310.1B | 18.83 | $3.71 | +2.39% |
| CSLLY | $88.00 | -0.18% | 170.3B | 32.33 | $2.72 | +1.51% |
| CMXHF | $173.00 | -1.54% | 83.8B | 31.74 | $5.45 | +1.60% |
| UCBJF | $211.99 | -0.73% | 40.3B | 32.87 | $6.45 | +0.75% |
| UCBJY | $106.54 | +1.60% | 39.7B | 32.19 | $3.23 | +0.76% |
| ARGNF | $547.60 | +0.00% | 33.5B | 33.43 | $16.37 | N/A |
| ODTC | $22,005.00 | +29.44% | 24.1B | 1.07 | $20,580.00 | N/A |
| IVBXF | $12.20 | +6.10% | 20.8B | -1215.00 | -$0.01 | N/A |
| SBHMY | $18.65 | +6.57% | 16.7B | 64.31 | $0.29 | +0.96% |
Stock Comparison
GSGTF vs NONOF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, NONOF has a market cap of 310.1B. Regarding current trading prices, GSGTF is priced at $0.24, while NONOF trades at $54.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas NONOF's P/E ratio is 18.83. In terms of profitability, GSGTF's ROE is +0.78%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, GSGTF is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check NONOF's competition here
GSGTF vs CSLLY Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, CSLLY has a market cap of 170.3B. Regarding current trading prices, GSGTF is priced at $0.24, while CSLLY trades at $88.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas CSLLY's P/E ratio is 32.33. In terms of profitability, GSGTF's ROE is +0.78%, compared to CSLLY's ROE of +0.26%. Regarding short-term risk, GSGTF is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check CSLLY's competition here
GSGTF vs CMXHF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, CMXHF has a market cap of 83.8B. Regarding current trading prices, GSGTF is priced at $0.24, while CMXHF trades at $173.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas CMXHF's P/E ratio is 31.74. In terms of profitability, GSGTF's ROE is +0.78%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, GSGTF is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check CMXHF's competition here
GSGTF vs UCBJF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, UCBJF has a market cap of 40.3B. Regarding current trading prices, GSGTF is priced at $0.24, while UCBJF trades at $211.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas UCBJF's P/E ratio is 32.87. In terms of profitability, GSGTF's ROE is +0.78%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, GSGTF is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check UCBJF's competition here
GSGTF vs UCBJY Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, UCBJY has a market cap of 39.7B. Regarding current trading prices, GSGTF is priced at $0.24, while UCBJY trades at $106.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas UCBJY's P/E ratio is 32.19. In terms of profitability, GSGTF's ROE is +0.78%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, GSGTF is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check UCBJY's competition here
GSGTF vs ARGNF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, ARGNF has a market cap of 33.5B. Regarding current trading prices, GSGTF is priced at $0.24, while ARGNF trades at $547.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas ARGNF's P/E ratio is 33.43. In terms of profitability, GSGTF's ROE is +0.78%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, GSGTF is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check ARGNF's competition here
GSGTF vs ODTC Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, GSGTF is priced at $0.24, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas ODTC's P/E ratio is 1.07. In terms of profitability, GSGTF's ROE is +0.78%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, GSGTF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check ODTC's competition here
GSGTF vs IVBXF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, IVBXF has a market cap of 20.8B. Regarding current trading prices, GSGTF is priced at $0.24, while IVBXF trades at $12.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas IVBXF's P/E ratio is -1215.00. In terms of profitability, GSGTF's ROE is +0.78%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, GSGTF is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check IVBXF's competition here
GSGTF vs SBHMY Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, SBHMY has a market cap of 16.7B. Regarding current trading prices, GSGTF is priced at $0.24, while SBHMY trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas SBHMY's P/E ratio is 64.31. In terms of profitability, GSGTF's ROE is +0.78%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, GSGTF is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check SBHMY's competition here
GSGTF vs WXIBF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, WXIBF has a market cap of 16.5B. Regarding current trading prices, GSGTF is priced at $0.24, while WXIBF trades at $4.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas WXIBF's P/E ratio is 36.77. In terms of profitability, GSGTF's ROE is +0.78%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, GSGTF is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check WXIBF's competition here
GSGTF vs WXXWY Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, WXXWY has a market cap of 16.4B. Regarding current trading prices, GSGTF is priced at $0.24, while WXXWY trades at $8.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas WXXWY's P/E ratio is 36.59. In terms of profitability, GSGTF's ROE is +0.78%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, GSGTF is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check WXXWY's competition here
GSGTF vs SBMFF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, SBMFF has a market cap of 16B. Regarding current trading prices, GSGTF is priced at $0.24, while SBMFF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas SBMFF's P/E ratio is 89.21. In terms of profitability, GSGTF's ROE is +0.78%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, GSGTF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check SBMFF's competition here
GSGTF vs GNMSF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, GNMSF has a market cap of 14.1B. Regarding current trading prices, GSGTF is priced at $0.24, while GNMSF trades at $229.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas GNMSF's P/E ratio is 13.46. In terms of profitability, GSGTF's ROE is +0.78%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, GSGTF is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check GNMSF's competition here
GSGTF vs TRSBF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, TRSBF has a market cap of 8.8B. Regarding current trading prices, GSGTF is priced at $0.24, while TRSBF trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas TRSBF's P/E ratio is 31.00. In terms of profitability, GSGTF's ROE is +0.78%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, GSGTF is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check TRSBF's competition here
GSGTF vs HAVLF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, HAVLF has a market cap of 5.6B. Regarding current trading prices, GSGTF is priced at $0.24, while HAVLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas HAVLF's P/E ratio is -0.01. In terms of profitability, GSGTF's ROE is +0.78%, compared to HAVLF's ROE of +0.00%. Regarding short-term risk, GSGTF is less volatile compared to HAVLF. This indicates potentially lower risk in terms of short-term price fluctuations for GSGTF.Check HAVLF's competition here
GSGTF vs ABCZF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, GSGTF is priced at $0.24, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, GSGTF's ROE is +0.78%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, GSGTF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check ABCZF's competition here
GSGTF vs AKBLF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, AKBLF has a market cap of 5B. Regarding current trading prices, GSGTF is priced at $0.24, while AKBLF trades at $30.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas AKBLF's P/E ratio is 33.86. In terms of profitability, GSGTF's ROE is +0.78%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, GSGTF is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check AKBLF's competition here
GSGTF vs GNNSF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, GNNSF has a market cap of 5B. Regarding current trading prices, GSGTF is priced at $0.24, while GNNSF trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas GNNSF's P/E ratio is -28.87. In terms of profitability, GSGTF's ROE is +0.78%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, GSGTF is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check GNNSF's competition here
GSGTF vs INCPF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, GSGTF is priced at $0.24, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas INCPF's P/E ratio is -108.67. In terms of profitability, GSGTF's ROE is +0.78%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, GSGTF is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check INCPF's competition here
GSGTF vs TLPPF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, TLPPF has a market cap of 4.6B. Regarding current trading prices, GSGTF is priced at $0.24, while TLPPF trades at $13.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas TLPPF's P/E ratio is 137.00. In terms of profitability, GSGTF's ROE is +0.78%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, GSGTF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check TLPPF's competition here
GSGTF vs LABFF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, GSGTF is priced at $0.24, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas LABFF's P/E ratio is 28.95. In terms of profitability, GSGTF's ROE is +0.78%, compared to LABFF's ROE of +0.38%. Regarding short-term risk, GSGTF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check LABFF's competition here
GSGTF vs AAVXF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, AAVXF has a market cap of 4.2B. Regarding current trading prices, GSGTF is priced at $0.24, while AAVXF trades at $66.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas AAVXF's P/E ratio is -19.25. In terms of profitability, GSGTF's ROE is +0.78%, compared to AAVXF's ROE of -2.11%. Regarding short-term risk, GSGTF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check AAVXF's competition here
GSGTF vs ZLDPF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, ZLDPF has a market cap of 4.1B. Regarding current trading prices, GSGTF is priced at $0.24, while ZLDPF trades at $54.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas ZLDPF's P/E ratio is -21.32. In terms of profitability, GSGTF's ROE is +0.78%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, GSGTF is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check ZLDPF's competition here
GSGTF vs CAMRF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, GSGTF is priced at $0.24, while CAMRF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas CAMRF's P/E ratio is 44.88. In terms of profitability, GSGTF's ROE is +0.78%, compared to CAMRF's ROE of +0.17%. Regarding short-term risk, GSGTF is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check CAMRF's competition here
GSGTF vs GLPGF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, GLPGF has a market cap of 3.2B. Regarding current trading prices, GSGTF is priced at $0.24, while GLPGF trades at $28.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas GLPGF's P/E ratio is -9.44. In terms of profitability, GSGTF's ROE is +0.78%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, GSGTF is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check GLPGF's competition here
GSGTF vs REGMF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, REGMF has a market cap of 3B. Regarding current trading prices, GSGTF is priced at $0.24, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas REGMF's P/E ratio is -13.32. In terms of profitability, GSGTF's ROE is +0.78%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, GSGTF is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check REGMF's competition here
GSGTF vs BVNKF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, BVNKF has a market cap of 2.9B. Regarding current trading prices, GSGTF is priced at $0.24, while BVNKF trades at $37.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas BVNKF's P/E ratio is 14.19. In terms of profitability, GSGTF's ROE is +0.78%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, GSGTF is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check BVNKF's competition here
GSGTF vs BVNRY Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, BVNRY has a market cap of 2.9B. Regarding current trading prices, GSGTF is priced at $0.24, while BVNRY trades at $12.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas BVNRY's P/E ratio is 13.90. In terms of profitability, GSGTF's ROE is +0.78%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, GSGTF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check BVNRY's competition here
GSGTF vs TKBIF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, GSGTF is priced at $0.24, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, GSGTF's ROE is +0.78%, compared to TKBIF's ROE of N/A. Regarding short-term risk, GSGTF is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check TKBIF's competition here
GSGTF vs MPSYF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, GSGTF is priced at $0.24, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, GSGTF's ROE is +0.78%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, GSGTF is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check MPSYF's competition here
GSGTF vs ONTTF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, ONTTF has a market cap of 2.7B. Regarding current trading prices, GSGTF is priced at $0.24, while ONTTF trades at $2.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas ONTTF's P/E ratio is -12.77. In terms of profitability, GSGTF's ROE is +0.78%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, GSGTF is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check ONTTF's competition here
GSGTF vs ASPHF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, ASPHF has a market cap of 2.4B. Regarding current trading prices, GSGTF is priced at $0.24, while ASPHF trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, GSGTF's ROE is +0.78%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, GSGTF is less volatile compared to ASPHF. This indicates potentially lower risk in terms of short-term price fluctuations for GSGTF.Check ASPHF's competition here
GSGTF vs GENSF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, GENSF has a market cap of 2.2B. Regarding current trading prices, GSGTF is priced at $0.24, while GENSF trades at $33.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas GENSF's P/E ratio is -416.12. In terms of profitability, GSGTF's ROE is +0.78%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, GSGTF is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check GENSF's competition here
GSGTF vs SHJBF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, SHJBF has a market cap of 2B. Regarding current trading prices, GSGTF is priced at $0.24, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas SHJBF's P/E ratio is -7.22. In terms of profitability, GSGTF's ROE is +0.78%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, GSGTF is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check SHJBF's competition here
GSGTF vs IUGNF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, IUGNF has a market cap of 1.9B. Regarding current trading prices, GSGTF is priced at $0.24, while IUGNF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas IUGNF's P/E ratio is -26.00. In terms of profitability, GSGTF's ROE is +0.78%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, GSGTF is less volatile compared to IUGNF. This indicates potentially lower risk in terms of short-term price fluctuations for GSGTF.Check IUGNF's competition here
GSGTF vs BTTAY Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, GSGTF is priced at $0.24, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, GSGTF's ROE is +0.78%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, GSGTF is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check BTTAY's competition here
GSGTF vs BRCTF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, GSGTF is priced at $0.24, while BRCTF trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas BRCTF's P/E ratio is 17.76. In terms of profitability, GSGTF's ROE is +0.78%, compared to BRCTF's ROE of +0.77%. Regarding short-term risk, GSGTF is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check BRCTF's competition here
GSGTF vs PHMMF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, PHMMF has a market cap of 1.7B. Regarding current trading prices, GSGTF is priced at $0.24, while PHMMF trades at $94.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas PHMMF's P/E ratio is 71.32. In terms of profitability, GSGTF's ROE is +0.78%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, GSGTF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check PHMMF's competition here
GSGTF vs BIESF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, GSGTF is priced at $0.24, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas BIESF's P/E ratio is -44.44. In terms of profitability, GSGTF's ROE is +0.78%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, GSGTF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check BIESF's competition here
GSGTF vs PPTDF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, PPTDF has a market cap of 1.5B. Regarding current trading prices, GSGTF is priced at $0.24, while PPTDF trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas PPTDF's P/E ratio is 15.24. In terms of profitability, GSGTF's ROE is +0.78%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, GSGTF is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check PPTDF's competition here
GSGTF vs CSBTF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, CSBTF has a market cap of 1.5B. Regarding current trading prices, GSGTF is priced at $0.24, while CSBTF trades at $37.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas CSBTF's P/E ratio is -291.54. In terms of profitability, GSGTF's ROE is +0.78%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, GSGTF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check CSBTF's competition here
GSGTF vs NURPF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, NURPF has a market cap of 1.4B. Regarding current trading prices, GSGTF is priced at $0.24, while NURPF trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas NURPF's P/E ratio is 15.40. In terms of profitability, GSGTF's ROE is +0.78%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, GSGTF is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check NURPF's competition here
GSGTF vs ASCLF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, ASCLF has a market cap of 1.3B. Regarding current trading prices, GSGTF is priced at $0.24, while ASCLF trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas ASCLF's P/E ratio is -34.50. In terms of profitability, GSGTF's ROE is +0.78%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, GSGTF is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check ASCLF's competition here
GSGTF vs MEOBF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, MEOBF has a market cap of 1.2B. Regarding current trading prices, GSGTF is priced at $0.24, while MEOBF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas MEOBF's P/E ratio is -16.08. In terms of profitability, GSGTF's ROE is +0.78%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, GSGTF is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check MEOBF's competition here
GSGTF vs SNBIF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, SNBIF has a market cap of 1B. Regarding current trading prices, GSGTF is priced at $0.24, while SNBIF trades at $14.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas SNBIF's P/E ratio is -34.00. In terms of profitability, GSGTF's ROE is +0.78%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, GSGTF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for GSGTF.Check SNBIF's competition here
GSGTF vs HBMHF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, HBMHF has a market cap of 766.2M. Regarding current trading prices, GSGTF is priced at $0.24, while HBMHF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas HBMHF's P/E ratio is 30.16. In terms of profitability, GSGTF's ROE is +0.78%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, GSGTF is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for GSGTF.Check HBMHF's competition here
GSGTF vs PHGUF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, PHGUF has a market cap of 685.1M. Regarding current trading prices, GSGTF is priced at $0.24, while PHGUF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas PHGUF's P/E ratio is -50.00. In terms of profitability, GSGTF's ROE is +0.78%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, GSGTF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check PHGUF's competition here
GSGTF vs INRLF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, INRLF has a market cap of 664.9M. Regarding current trading prices, GSGTF is priced at $0.24, while INRLF trades at $3.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas INRLF's P/E ratio is -5.92. In terms of profitability, GSGTF's ROE is +0.78%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, GSGTF is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check INRLF's competition here
GSGTF vs BPMUF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, BPMUF has a market cap of 636.8M. Regarding current trading prices, GSGTF is priced at $0.24, while BPMUF trades at $61.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas BPMUF's P/E ratio is 7.05. In terms of profitability, GSGTF's ROE is +0.78%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, GSGTF is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check BPMUF's competition here
GSGTF vs SOLTF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, SOLTF has a market cap of 578.3M. Regarding current trading prices, GSGTF is priced at $0.24, while SOLTF trades at $6.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas SOLTF's P/E ratio is -35.50. In terms of profitability, GSGTF's ROE is +0.78%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, GSGTF is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check SOLTF's competition here
GSGTF vs CLAZF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, CLAZF has a market cap of 531.7M. Regarding current trading prices, GSGTF is priced at $0.24, while CLAZF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas CLAZF's P/E ratio is 0.09. In terms of profitability, GSGTF's ROE is +0.78%, compared to CLAZF's ROE of +0.00%. Regarding short-term risk, GSGTF is more volatile compared to CLAZF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check CLAZF's competition here
GSGTF vs IVEVF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, IVEVF has a market cap of 506.3M. Regarding current trading prices, GSGTF is priced at $0.24, while IVEVF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, GSGTF's ROE is +0.78%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, GSGTF is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check IVEVF's competition here
GSGTF vs CKDXF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, CKDXF has a market cap of 485M. Regarding current trading prices, GSGTF is priced at $0.24, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, GSGTF's ROE is +0.78%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, GSGTF is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check CKDXF's competition here
GSGTF vs VBIZF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, VBIZF has a market cap of 472.2M. Regarding current trading prices, GSGTF is priced at $0.24, while VBIZF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas VBIZF's P/E ratio is 22.70. In terms of profitability, GSGTF's ROE is +0.78%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, GSGTF is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check VBIZF's competition here
GSGTF vs CSPHF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, CSPHF has a market cap of 467.8M. Regarding current trading prices, GSGTF is priced at $0.24, while CSPHF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas CSPHF's P/E ratio is -32.10. In terms of profitability, GSGTF's ROE is +0.78%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, GSGTF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for GSGTF.Check CSPHF's competition here
GSGTF vs MDCLF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, MDCLF has a market cap of 463.1M. Regarding current trading prices, GSGTF is priced at $0.24, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas MDCLF's P/E ratio is -10.45. In terms of profitability, GSGTF's ROE is +0.78%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, GSGTF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check MDCLF's competition here
GSGTF vs RAONF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, GSGTF is priced at $0.24, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas RAONF's P/E ratio is -43.33. In terms of profitability, GSGTF's ROE is +0.78%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, GSGTF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for GSGTF.Check RAONF's competition here
GSGTF vs PRNAF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, PRNAF has a market cap of 448.1M. Regarding current trading prices, GSGTF is priced at $0.24, while PRNAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, GSGTF's ROE is +0.78%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, GSGTF is less volatile compared to PRNAF. This indicates potentially lower risk in terms of short-term price fluctuations for GSGTF.Check PRNAF's competition here
GSGTF vs BOVNF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, GSGTF is priced at $0.24, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas BOVNF's P/E ratio is -8.84. In terms of profitability, GSGTF's ROE is +0.78%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, GSGTF is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check BOVNF's competition here
GSGTF vs TBGNF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, GSGTF is priced at $0.24, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, GSGTF's ROE is +0.78%, compared to TBGNF's ROE of N/A. Regarding short-term risk, GSGTF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check TBGNF's competition here
GSGTF vs CLVLF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, CLVLF has a market cap of 401M. Regarding current trading prices, GSGTF is priced at $0.24, while CLVLF trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas CLVLF's P/E ratio is 15.69. In terms of profitability, GSGTF's ROE is +0.78%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, GSGTF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check CLVLF's competition here
GSGTF vs PTCHF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, PTCHF has a market cap of 396.4M. Regarding current trading prices, GSGTF is priced at $0.24, while PTCHF trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas PTCHF's P/E ratio is 7.86. In terms of profitability, GSGTF's ROE is +0.78%, compared to PTCHF's ROE of +0.15%. Regarding short-term risk, GSGTF is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check PTCHF's competition here
GSGTF vs CLVLY Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, CLVLY has a market cap of 389.5M. Regarding current trading prices, GSGTF is priced at $0.24, while CLVLY trades at $7.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas CLVLY's P/E ratio is 15.06. In terms of profitability, GSGTF's ROE is +0.78%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, GSGTF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check CLVLY's competition here
GSGTF vs NWBO Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, NWBO has a market cap of 370M. Regarding current trading prices, GSGTF is priced at $0.24, while NWBO trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas NWBO's P/E ratio is -4.23. In terms of profitability, GSGTF's ROE is +0.78%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, GSGTF is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check NWBO's competition here
GSGTF vs CLTEF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, CLTEF has a market cap of 361M. Regarding current trading prices, GSGTF is priced at $0.24, while CLTEF trades at $5.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas CLTEF's P/E ratio is -5.05. In terms of profitability, GSGTF's ROE is +0.78%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, GSGTF is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check CLTEF's competition here
GSGTF vs CYDY Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, CYDY has a market cap of 352.5M. Regarding current trading prices, GSGTF is priced at $0.24, while CYDY trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas CYDY's P/E ratio is -14.30. In terms of profitability, GSGTF's ROE is +0.78%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, GSGTF is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check CYDY's competition here
GSGTF vs HLOSF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, HLOSF has a market cap of 346.9M. Regarding current trading prices, GSGTF is priced at $0.24, while HLOSF trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas HLOSF's P/E ratio is -10.23. In terms of profitability, GSGTF's ROE is +0.78%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, GSGTF is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check HLOSF's competition here
GSGTF vs PRRUF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, PRRUF has a market cap of 324.5M. Regarding current trading prices, GSGTF is priced at $0.24, while PRRUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas PRRUF's P/E ratio is -11.05. In terms of profitability, GSGTF's ROE is +0.78%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, GSGTF is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check PRRUF's competition here
GSGTF vs IDRSF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, IDRSF has a market cap of 306.2M. Regarding current trading prices, GSGTF is priced at $0.24, while IDRSF trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas IDRSF's P/E ratio is -0.88. In terms of profitability, GSGTF's ROE is +0.78%, compared to IDRSF's ROE of +0.20%. Regarding short-term risk, GSGTF is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check IDRSF's competition here
GSGTF vs BXPHF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, BXPHF has a market cap of 294.2M. Regarding current trading prices, GSGTF is priced at $0.24, while BXPHF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas BXPHF's P/E ratio is -15.00. In terms of profitability, GSGTF's ROE is +0.78%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, GSGTF is more volatile compared to BXPHF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check BXPHF's competition here
GSGTF vs PBBIF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, GSGTF is priced at $0.24, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, GSGTF's ROE is +0.78%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, GSGTF is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check PBBIF's competition here
GSGTF vs HNSBF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, HNSBF has a market cap of 279.7M. Regarding current trading prices, GSGTF is priced at $0.24, while HNSBF trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas HNSBF's P/E ratio is -3.67. In terms of profitability, GSGTF's ROE is +0.78%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, GSGTF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check HNSBF's competition here
GSGTF vs GNFTF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, GNFTF has a market cap of 276.4M. Regarding current trading prices, GSGTF is priced at $0.24, while GNFTF trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas GNFTF's P/E ratio is 138.75. In terms of profitability, GSGTF's ROE is +0.78%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, GSGTF is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check GNFTF's competition here
GSGTF vs AVCTF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, AVCTF has a market cap of 269.3M. Regarding current trading prices, GSGTF is priced at $0.24, while AVCTF trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas AVCTF's P/E ratio is -5.59. In terms of profitability, GSGTF's ROE is +0.78%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, GSGTF is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check AVCTF's competition here
GSGTF vs TRGNF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, TRGNF has a market cap of 264.8M. Regarding current trading prices, GSGTF is priced at $0.24, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas TRGNF's P/E ratio is -5.88. In terms of profitability, GSGTF's ROE is +0.78%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, GSGTF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for GSGTF.Check TRGNF's competition here
GSGTF vs OPORF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, OPORF has a market cap of 240.5M. Regarding current trading prices, GSGTF is priced at $0.24, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas OPORF's P/E ratio is 17.50. In terms of profitability, GSGTF's ROE is +0.78%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, GSGTF is more volatile compared to OPORF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check OPORF's competition here
GSGTF vs SPHDF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, SPHDF has a market cap of 237.9M. Regarding current trading prices, GSGTF is priced at $0.24, while SPHDF trades at $18.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas SPHDF's P/E ratio is -3.95. In terms of profitability, GSGTF's ROE is +0.78%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, GSGTF is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check SPHDF's competition here
GSGTF vs ORYZF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, GSGTF is priced at $0.24, while ORYZF trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, GSGTF's ROE is +0.78%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, GSGTF is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check ORYZF's competition here
GSGTF vs NWPHF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, GSGTF is priced at $0.24, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas NWPHF's P/E ratio is N/A. In terms of profitability, GSGTF's ROE is +0.78%, compared to NWPHF's ROE of N/A. Regarding short-term risk, GSGTF is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check NWPHF's competition here
GSGTF vs SLNCF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, SLNCF has a market cap of 226.7M. Regarding current trading prices, GSGTF is priced at $0.24, while SLNCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas SLNCF's P/E ratio is -3.14. In terms of profitability, GSGTF's ROE is +0.78%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, GSGTF is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check SLNCF's competition here
GSGTF vs FPHAF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, GSGTF is priced at $0.24, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, GSGTF's ROE is +0.78%, compared to FPHAF's ROE of N/A. Regarding short-term risk, GSGTF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check FPHAF's competition here
GSGTF vs VSBC Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, GSGTF is priced at $0.24, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas VSBC's P/E ratio is N/A. In terms of profitability, GSGTF's ROE is +0.78%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, GSGTF is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check VSBC's competition here
GSGTF vs FGHQF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, GSGTF is priced at $0.24, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, GSGTF's ROE is +0.78%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, GSGTF is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check FGHQF's competition here
GSGTF vs RECEF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, RECEF has a market cap of 192.9M. Regarding current trading prices, GSGTF is priced at $0.24, while RECEF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas RECEF's P/E ratio is -8.33. In terms of profitability, GSGTF's ROE is +0.78%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, GSGTF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for GSGTF.Check RECEF's competition here
GSGTF vs AMGXF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, AMGXF has a market cap of 191.3M. Regarding current trading prices, GSGTF is priced at $0.24, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas AMGXF's P/E ratio is -0.69. In terms of profitability, GSGTF's ROE is +0.78%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, GSGTF is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check AMGXF's competition here
GSGTF vs CMVLF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, CMVLF has a market cap of 187.4M. Regarding current trading prices, GSGTF is priced at $0.24, while CMVLF trades at $3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas CMVLF's P/E ratio is -3.88. In terms of profitability, GSGTF's ROE is +0.78%, compared to CMVLF's ROE of -0.46%. Regarding short-term risk, GSGTF is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check CMVLF's competition here
GSGTF vs NGENF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, NGENF has a market cap of 186.6M. Regarding current trading prices, GSGTF is priced at $0.24, while NGENF trades at $2.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas NGENF's P/E ratio is -9.14. In terms of profitability, GSGTF's ROE is +0.78%, compared to NGENF's ROE of -4.00%. Regarding short-term risk, GSGTF is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check NGENF's competition here
GSGTF vs BSEM Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, BSEM has a market cap of 181.7M. Regarding current trading prices, GSGTF is priced at $0.24, while BSEM trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas BSEM's P/E ratio is 7.56. In terms of profitability, GSGTF's ROE is +0.78%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, GSGTF is more volatile compared to BSEM. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check BSEM's competition here
GSGTF vs IPHYF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, IPHYF has a market cap of 179.7M. Regarding current trading prices, GSGTF is priced at $0.24, while IPHYF trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas IPHYF's P/E ratio is -2.71. In terms of profitability, GSGTF's ROE is +0.78%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, GSGTF is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for GSGTF.Check IPHYF's competition here
GSGTF vs ADOCY Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, GSGTF is priced at $0.24, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, GSGTF's ROE is +0.78%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, GSGTF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check ADOCY's competition here
GSGTF vs BRIBF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, BRIBF has a market cap of 169.3M. Regarding current trading prices, GSGTF is priced at $0.24, while BRIBF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas BRIBF's P/E ratio is -2.31. In terms of profitability, GSGTF's ROE is +0.78%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, GSGTF is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check BRIBF's competition here
GSGTF vs MLLCF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, GSGTF is priced at $0.24, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas MLLCF's P/E ratio is -1.98. In terms of profitability, GSGTF's ROE is +0.78%, compared to MLLCF's ROE of -0.42%. Regarding short-term risk, GSGTF is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check MLLCF's competition here
GSGTF vs HOFBF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, HOFBF has a market cap of 130.4M. Regarding current trading prices, GSGTF is priced at $0.24, while HOFBF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas HOFBF's P/E ratio is -11.00. In terms of profitability, GSGTF's ROE is +0.78%, compared to HOFBF's ROE of -1.54%. Regarding short-term risk, GSGTF is more volatile compared to HOFBF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check HOFBF's competition here
GSGTF vs AAPGV Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, GSGTF is priced at $0.24, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas AAPGV's P/E ratio is N/A. In terms of profitability, GSGTF's ROE is +0.78%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, GSGTF is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check AAPGV's competition here
GSGTF vs PBIGF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, PBIGF has a market cap of 125.9M. Regarding current trading prices, GSGTF is priced at $0.24, while PBIGF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas PBIGF's P/E ratio is -7.92. In terms of profitability, GSGTF's ROE is +0.78%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, GSGTF is more volatile compared to PBIGF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check PBIGF's competition here
GSGTF vs SCNLF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, SCNLF has a market cap of 123.5M. Regarding current trading prices, GSGTF is priced at $0.24, while SCNLF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas SCNLF's P/E ratio is -3.97. In terms of profitability, GSGTF's ROE is +0.78%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, GSGTF is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check SCNLF's competition here
GSGTF vs PSTTF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, GSGTF is priced at $0.24, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, GSGTF's ROE is +0.78%, compared to PSTTF's ROE of N/A. Regarding short-term risk, GSGTF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check PSTTF's competition here
GSGTF vs EPRXF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, GSGTF is priced at $0.24, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, GSGTF's ROE is +0.78%, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, GSGTF is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for GSGTF.Check EPRXF's competition here
GSGTF vs POLBF Comparison July 2025
GSGTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GSGTF stands at 478.2M. In comparison, POLBF has a market cap of 105.3M. Regarding current trading prices, GSGTF is priced at $0.24, while POLBF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GSGTF currently has a P/E ratio of -8.16, whereas POLBF's P/E ratio is -7.55. In terms of profitability, GSGTF's ROE is +0.78%, compared to POLBF's ROE of -0.33%. Regarding short-term risk, GSGTF is less volatile compared to POLBF. This indicates potentially lower risk in terms of short-term price fluctuations for GSGTF.Check POLBF's competition here